Interventions Facilitating Patient-Mediated or Provider-Mediated Cancer Predisposition Cascade Genetic Screening
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5961
Special Issue Editor
2. Robert Wood Johnson Foundation Fellow, Princeton, NJ, USA
Interests: cancer prevention and control; web-based and family-focused interventions for hereditary cancer syndromes; cancer predisposition cascade genetic testing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In many countries around the world, privacy laws for the protection of information regarding genetic testing dictate that the communication of test results and predisposition to hereditary cancer syndromes (i.e., HBOC and Lynch syndrome) are initiated by the person identified with the pathogenic variant (patient-mediated contact) and not from the medical clinic (provider-mediated contact). An essentially medical task, i.e., communication of cancer risk and possible testing, relies on carriers of pathogenic variants as primary communicators with their at-risk relatives. This strategy has significant limitations in both ensuring contact with the appropriate people and the transmission of accurate information and hinders the potential for cancer predisposition cascade genetic testing.
A recent meta-analysis synthesized a growing body of literature suggesting that provider-mediated contact of relatives is significantly more successful than patient-mediated contact. However, a shift in the care delivery paradigm needs to be supported by evidence and/or arguments for (1) the acceptability of this approach among patients and clinicians; (2) the conditions under which a provider-mediated approach would not conflict with privacy laws; and (3) the feasibility of necessary changes in infrastructure. Technology could play a significant role in overcoming some of these obstacles.
This Special Issue of Cancers provides an opportunity to describe recent and original research and/or reviews regarding patient-mediated or provider-mediated cancer predisposition cascade genetic screening. We are particularly interested in the development or application of new platforms, and in different and innovative approaches that access genetic services and cascade genetic screening. If you would like to discuss an idea for a paper before committing, please contact the Guest Editor or the Editorial Office.
Prof. Dr. Maria C. Katapodi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- access to genetic services
- cascade genetic testing
- direct contact to relatives
- family communication
- genetic counseling
- telegenetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.